Gabelli Funds’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Hold |
100,000
| – | – | ﹤0.01% | 1162 |
|
|
2025
Q1 | $118K | Hold |
100,000
| – | – | ﹤0.01% | 1037 |
|
|
2024
Q4 | $183K | Hold |
100,000
| – | – | ﹤0.01% | 1023 |
|
|
2024
Q3 | $170K | Hold |
100,000
| – | – | ﹤0.01% | 1022 |
|
|
2024
Q2 | $137K | Hold |
100,000
| – | – | ﹤0.01% | 1015 |
|
|
2024
Q1 | $375K | Hold |
100,000
| – | – | ﹤0.01% | 922 |
|
|
2023
Q4 | $981K | Hold |
100,000
| – | – | 0.01% | 782 |
|
|
2023
Q3 | $835K | Hold |
100,000
| – | – | 0.01% | 825 |
|
|
2023
Q2 | $1.33M | Hold |
100,000
| – | – | 0.01% | 745 |
|
|
2023
Q1 | $1.16M | Hold |
100,000
| – | – | 0.01% | 774 |
|
|
2022
Q4 | $818K | Hold |
100,000
| – | – | 0.01% | 842 |
|
|
2022
Q3 | $581K | Sell |
100,000
-8,302
| -8% | -$48.2K | ﹤0.01% | 947 |
|
|
2022
Q2 | $479K | Sell |
108,302
-94,698
| -47% | -$419K | ﹤0.01% | 1028 |
|
|
2022
Q1 | $1.85M | Hold |
203,000
| – | – | 0.01% | 741 |
|
|
2021
Q4 | $4.15M | Buy |
+203,000
| New | +$4.15M | 0.03% | 557 |
|
|
2020
Q4 | – | Sell |
-276,000
| Closed | -$2.72M | – | 1229 |
|
|
2020
Q3 | $2.72M | Sell |
276,000
-2,064,887
| -88% | -$20.4M | 0.02% | 598 |
|
|
2020
Q2 | $8.08M | Sell |
2,340,887
-27,000
| -1% | -$93.1K | 0.07% | 340 |
|
|
2020
Q1 | $7.25M | Sell |
2,367,887
-72,011
| -3% | -$220K | 0.06% | 339 |
|
|
2019
Q4 | $12.5M | Sell |
2,439,898
-357,361
| -13% | -$1.84M | 0.08% | 295 |
|
|
2019
Q3 | $14.4M | Sell |
2,797,259
-60,486
| -2% | -$312K | 0.1% | 274 |
|
|
2019
Q2 | $17.3M | Sell |
2,857,745
-42,361
| -1% | -$256K | 0.11% | 245 |
|
|
2019
Q1 | $21M | Buy |
2,900,106
+1,155,636
| +66% | +$8.36M | 0.13% | 216 |
|
|
2018
Q4 | $12.9M | Buy |
+1,744,470
| New | +$12.9M | 0.09% | 298 |
|